share_log

中國人壽:關於合夥企業的關連交易進展公告

CHINA LIFE: Announcement on the Progress of Connected Transaction in relation to a Partnership

HKEX ·  Apr 26 18:41

Summary by Futu AI

中國人壽保險股份有限公司(簡稱「中國人壽」)宣布,計劃於2024年12月31日前與國壽置業簽訂補充協議,增加對合夥企業的認繳出資額,並將合夥企業的經營期限延長。該合夥企業為雙方於2020年11月20日成立,專注於中國一線及強二線城市不動產項目的股權及配套投資。本次增資後,合夥企業的總認繳出資額將由人民幣9,001,000,000元增至人民幣13,901,000,000元,其中中國人壽的出資額將由人民幣9,000,000,000元增至人民幣13,900,000,000元。國壽置業的出資額保持不變。此次增資為關連交易,但由於增資比例低於5%,根據上市規則第14A章,無需獨立股東批准。合夥企業將投資...展開全部
中國人壽保險股份有限公司(簡稱「中國人壽」)宣布,計劃於2024年12月31日前與國壽置業簽訂補充協議,增加對合夥企業的認繳出資額,並將合夥企業的經營期限延長。該合夥企業為雙方於2020年11月20日成立,專注於中國一線及強二線城市不動產項目的股權及配套投資。本次增資後,合夥企業的總認繳出資額將由人民幣9,001,000,000元增至人民幣13,901,000,000元,其中中國人壽的出資額將由人民幣9,000,000,000元增至人民幣13,900,000,000元。國壽置業的出資額保持不變。此次增資為關連交易,但由於增資比例低於5%,根據上市規則第14A章,無需獨立股東批准。合夥企業將投資於北京星泰通港置業有限公司(項目公司)的頤堤港二期項目,該項目位於北京市大望京商圈。中國人壽為遠洋集團的主要股東,持有其29.59%的股權,但遠洋集團並非中國人壽的關連人士。本次增資的資金將用於收購及符合合夥協議投資方向的其他項目。中國人壽是中國領先的人壽保險公司,提供多種保險及金融服務,其控股股東為中國人壽保險(集團)公司。
China Life Insurance Co., Ltd. (“China Life”) announced that it plans to conclude a supplemental agreement with Guoshu Real Estate before December 31, 2024 to increase the amount of authorized payments to the partner enterprises and extend the operating period of the partnership. The partnership was established on 20 November 2020 for the two parties to focus on equity and ancillary investments in China's first-line and strong-second-line urban real estate projects. Following this capital increase, the total authorized disbursement of the partnership will increase from RMB9,001,000,000 to RMB13,901,000,000, and the outlay of China Life will increase from RMB9,000,000,000 to RMB13,900,000,000. The capital outflow of National Life Investments remained unchanged. The capital increase is a connected transaction but is not subject to the approval of...Show More
China Life Insurance Co., Ltd. (“China Life”) announced that it plans to conclude a supplemental agreement with Guoshu Real Estate before December 31, 2024 to increase the amount of authorized payments to the partner enterprises and extend the operating period of the partnership. The partnership was established on 20 November 2020 for the two parties to focus on equity and ancillary investments in China's first-line and strong-second-line urban real estate projects. Following this capital increase, the total authorized disbursement of the partnership will increase from RMB9,001,000,000 to RMB13,901,000,000, and the outlay of China Life will increase from RMB9,000,000,000 to RMB13,900,000,000. The capital outflow of National Life Investments remained unchanged. The capital increase is a connected transaction but is not subject to the approval of independent shareholders under Chapter 14A of the Listing Rules, as the capital increase is less than 5%. The partnership will invest in the Yitei Port Phase II project of Beijing Xingtai Tongang Real Estate Co., Ltd. (Project Company), which is located in the Dawangjing Business District of Beijing. China Life is the major shareholder of Ocean Group, holding 29.59% of its shareholding, but Ocean Group is not an affiliate of China Life. THE FUNDS FROM THIS INCREASE WILL BE USED FOR ACQUISITIONS AND OTHER PROJECTS IN THE DIRECTION OF INVESTMENT UNDER THE PARTNERSHIP AGREEMENT. China Life is a leading life insurance company in China, offering a wide range of insurance and financial services. Its controlling shareholder is China Life Insurance (Group).

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.